• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS 1 MULTIFOCAL; MULTIFOCAL IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS 1 MULTIFOCAL; MULTIFOCAL IOLS Back to Search Results
Model Number ZLB00
Medical Device Problem Codes Dent in Material (2526); Scratched Material (3020)
Health Effect - Clinical Codes Visual Disturbances (2140); No Code Available (3191)
Date of Event 10/04/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b(4).Device evaluation: according to the initial report, the lens was cut in half and discarded.As the product does not return for the evaluation, the complaint cannot be confirmed and either a product deficiency can be confirmed.Manufacturing record review: the manufacturing process record was evaluated and revealed that the product was manufactured and released according to specifications.A search revealed that no other complaints were received from this production order.Conclusion: as a result of the investigation there is no indication of a product quality deficiency and the reported issue could not be verified.An attempt has been made to obtain missing information; however, no definitive response has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that a zlb00 intraocular lens (iol) was explanted due to the patient seeing a diagonal line, x2 matching crease in iol (20/20 with line in vision).This was described as scratch on iol.At explant there was incision enlargement and sutures required, but no vitrectomy.The lens was cut in half and discarded.New lens implanted was the same model and diopter.The iol exchange was successful.It was also mentioned to allow about 3.5 months for neuroadaptation and to try dry eye treatments.No other information was provided.
 
Additional Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are (b)(4) and capa(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS 1 MULTIFOCAL
Common Device Name
MULTIFOCAL IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key9281130
Report Number2648035-2019-01167
Device Sequence Number11383830
Product Code MFK
UDI-Device Identifier05050474560529
UDI-Public(01)05050474560529(17)221129
Combination Product (Y/N)Y
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/06/2020
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/29/2022
Device Model NumberZLB00
Device Catalogue NumberZLB00U0125
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 10/08/2019
Supplement Date Received by Manufacturer10/25/2020
Initial Report FDA Received Date11/05/2019
Supplement Report FDA Received Date11/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age66 YR
Date Report Sent to FDA01/01/2005
-
-